搜索
Taysha Gene Therapies Inc
TSHA添加自选
6.650USD
-0.160-2.35%
收盘 07/01, 16:00（美东）报价延迟15分钟
2.13B总市值
亏损市盈率 TTM
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Manning (Paul B.)
8.91%
RA Capital Management, LP
8.20%
Avoro Capital Advisors LLC
6.49%
Morgan Stanley & Co. LLC
6.21%
BlackRock Institutional Trust Company, N.A.
5.76%
其他
64.43%
持股股东
持股股东
占比
Manning (Paul B.)
8.91%
RA Capital Management, LP
8.20%
Avoro Capital Advisors LLC
6.49%
Morgan Stanley & Co. LLC
6.21%
BlackRock Institutional Trust Company, N.A.
5.76%
其他
64.43%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
30.02%
Investment Advisor
26.55%
Hedge Fund
15.84%
Research Firm
12.51%
Individual Investor
10.08%
Venture Capital
8.20%
Pension Fund
1.46%
Sovereign Wealth Fund
0.64%
Corporation
0.53%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
369
287.49M
100.06%
+5.52M
2025Q4
332
268.88M
98.16%
-15.50M
2025Q3
289
260.55M
95.12%
+66.39M
2025Q2
275
201.11M
79.83%
-18.39M
2025Q1
280
208.55M
85.47%
-19.89M
2024Q4
274
206.61M
100.79%
-12.49M
2024Q3
266
194.14M
94.73%
-23.74M
2024Q2
250
196.13M
97.09%
+4.27M
2024Q1
251
185.84M
99.33%
-1.52M
2023Q4
229
175.44M
93.86%
-4.17M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Manning (Paul B.)
25.60M
9.35%
+750.00K
+3.02%
May 30, 2025
RA Capital Management, LP
23.56M
8.6%
--
--
Sep 30, 2025
Avoro Capital Advisors LLC
21.70M
7.92%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
19.08M
6.97%
+4.42M
+30.12%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
15.03M
5.49%
+2.94M
+24.29%
Sep 30, 2025
RTW Investments L.P.
24.35M
8.89%
-667.29K
-2.67%
Sep 30, 2025
Vestal Point Capital, LP
5.50M
2.01%
+2.50M
+83.33%
Sep 30, 2025
Fidelity Management & Research Company LLC
14.59M
5.33%
-1.03M
-6.62%
Sep 30, 2025
Goldman Sachs & Company, Inc.
13.20M
4.82%
+676.68K
+5.40%
Sep 30, 2025
State Street Investment Management (US)
7.24M
2.64%
+2.10M
+40.83%
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月2日 周二
更新时间: 12月2日 周二
机构名称
占比
iShares Neuroscience and Healthcare ETF
1.83%
Virtus LifeSci Biotech Clinical Trials ETF
1.27%
Texas Capital Texas Small Cap Equity Index ETF
0.47%
State Street SPDR S&P Biotech ETF
0.29%
iShares Micro-Cap ETF
0.2%
Direxion Daily S&P Biotech Bull 3X Shares
0.18%
Vanguard US Momentum Factor ETF
0.13%
Invesco Nasdaq Biotechnology ETF
0.13%
ProShares Ultra Nasdaq Biotechnology
0.13%
Goldman Sachs Innovate Equity ETF
0.1%
查看更多
iShares Neuroscience and Healthcare ETF
占比1.83%
Virtus LifeSci Biotech Clinical Trials ETF
占比1.27%
Texas Capital Texas Small Cap Equity Index ETF
占比0.47%
State Street SPDR S&P Biotech ETF
占比0.29%
iShares Micro-Cap ETF
占比0.2%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.18%
Vanguard US Momentum Factor ETF
占比0.13%
Invesco Nasdaq Biotechnology ETF
占比0.13%
ProShares Ultra Nasdaq Biotechnology
占比0.13%
Goldman Sachs Innovate Equity ETF
占比0.1%